We are live on
!
Find out more
Rocket Pharmaceuticals
RCKT
RCKT
194 hedge funds and large institutions have $2.69B invested in Rocket Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 68 increasing their positions, 65 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
162% more call options, than puts
Call options by funds: $33.1M | Put options by funds: $12.7M
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
47% more capital invested
Capital invested by funds: $1.83B → $2.69B (+$854M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
11% more funds holding
Funds holding: 175 → 194 (+19)
5% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 65
11.62% less ownership
Funds ownership: 111.02% → 99.4% (-12%)
Holders
194
Holders Change
+19
Holders Change %
+10.86%
% of All Funds
2.83%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.12%
New
37
Increased
68
Reduced
65
Closed
17
Calls
$33.1M
Puts
$12.7M
Net Calls
+$20.5M
Net Calls Change
+$3.42M
Top Buyers
| 1 |
Pictet Asset Management
Carouge,
Switzerland
|
+$29.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.6M |
| 3 |
BlackRock
New York
|
+$18M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$10.2M |
| 5 |
Morgan Stanley
New York
|
+$9.83M |
Top Sellers
| 1 |
MC
Maverick Capital
Dallas,
Texas
|
-$35.2M |
| 2 |
Millennium Management
New York
|
-$21M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$15.4M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$9.16M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.99M |
